Cordex‑HSC
Hematopoietic stem cell transplantation for AML, ALL, aplastic anemia and related disorders
Phase 2/3Active
Key Facts
Indication
Hematopoietic stem cell transplantation for AML, ALL, aplastic anemia and related disorders
Phase
Phase 2/3
Status
Active
Company
About Cordex Biologics
Cordex uses UM171‑expanded stem cells to deliver curative, one‑time cell therapies for transplant patients.
View full company profile